Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: Potential value in molecular staging of prostate cancer

International Journal of Urology

Volumn 14, Issue 7, 2007, Pages 635-643

  Joung, Jae Young ^a   Yang, Seung Ok ^a   Jeong, In Gab ^a   Han, Kyung Suk ^a   Seo, Ho Kyung ^a   Chung, Jinsoo ^a   Park, Weon Seo ^a   Lee, Kang Hyun ^a  

^a National Cancer Center   (South Korea)

Author keywords

Prostate cancer; Prostate stem cell antigen; Reverse transcriptase polymerase chain reaction

Indexed keywords

PROSTATE STEM CELL ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HORMONAL THERAPY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATE DISEASE; PROSTATECTOMY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMINAL VESICLE DISEASE; STEM CELL; TISSUE MICROARRAY; UNIVARIATE ANALYSIS; VEIN EMBOLISM;

AGED; AGED, 80 AND OVER; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34447538484     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2007.01787.x     Document Type: Article

References (26)

1. Greenlee RT, Murray T, Bolden S et al. Cancer statistics, 2000. Cancer J. Clin. 2000 50 : 7 33.
2. Park SK, Sakoda LC, Kang D et al. Rising prostate cancer rates in south Korea. Prostate 2006 66 : 1285 91.
3. Mejean A, Vona G, Nalpas B et al. Detection of circulating prostate derived cells in patients with prostate adenocarcinoma in an independent risk factor for tumor recurrence. J. Urol. 2000 163 : 2022 9.
4. Hara N, Kasahara T, Kawasaki T et al. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer. Clin. Cancer Res. 2002 8 : 1794 9.
5. Zippelius A, Pantel K. RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors. An overview. Ann. NY Acad. Sci. 2000 906 : 110 23.
6. Vessella RL, Riley DE, Blouke KA. A sensitive method for detection of a prostate tumor cell marker using the polymerase chain reaction. J. Urol. 1992 148 (Suppl. A 441.
7. Moreno JG, Croce CM, Fischer R et al. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res. 1992 52 : 6110 12.
8. Chung H, Cheon SH, Kim C-S. The role of PSA-mRNA RT-PCR in molecular staging of prostate cancer. Korean J. Urol. 1990 40 : 1137 44.
9. Katz AE, Olsson CA, Raffo AJ et al. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology 1994 43 : 765 75.
10. Sokoloff MH, Tso CL, Kaboo R et al. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J. Urol. 1996 156 : 1560 6.
11. Su SL, Boynton AL, Holmes EH et al. Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reaction. Semin. Surg. Oncol. 2000 18 : 17 28.
12. Olsson CA, de Vries GM, Buttyan R et al. Reverse transcriptase-polymerase chain reaction assays for prostate cancer. Urol. Clin. North Am. 1997 24 : 367 78.
13. De la Taille A, Olsson CA, Buttyan R et al. Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy. Int. J. Cancer 1999 84 : 360 4.
14. Kim BW, Kwen SW, Chang SK et al. Molecular staging of micrometastasis in prostate cancer using RT-PCR. Korean J. Urol. 1999 40 : 41 6.
15. Reiter RE, Gu Z, Watabe T et al. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc. Natl Acad. Sci. USA 1998 95 : 1735 40.
16. Saffran DC, Raitano AB, Hubert RS et al. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts. Proc. Natl Acad. Sci. USA 2001 98 : 2568.
17. Gu Z, Thomas G, Yamashiro J et al. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene 2000 19 : 1288.
18. Noda S, Kosugi A, Saitoh S et al. Protection from anti-TCR/CD3-induced apoptosis in immature thymocytes by a signal through thymic shared antigen-1/stem cell antigen-2. J. Exp. Med. 1996 185 : 2355 60.
19. Jenkins RB, Qian J, Lieber MM et al. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res. 1997 57 : 524.
20. Cunha AC, Weigle B, Kiessling A et al. Tissue-specificity of prostate specific antigens: comparative analysis of transcript levels in prostate and non-prostatic tissues. Cancer Lett. 2006 236 : 229 38.
21. Gu Z, Thomas G, Yamashiro J et al. Prostate stem cell antigen (PSCA) expression increase with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene 2000 19 : 1288 96.
22. Gao CL, Dean RC, Pinto A et al. Detection of circulating prostate specific antigen expression prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction. J. Urol. 1999 161 : 1070 6.
23. Oefelein MG, Ignatoff JM, Clemens JQ et al. Clinical and molecular followup after radical retropubic prostatectomy. J. Urol. 1999 162 : 307 11.
24. Zhigang Z, Wenlu S. Complete androgen ablation suppresses prostate stem cell antigen (PSCA) mRNA expression in human prostate carcinoma. Prostate 2005 65 : 299 305.
25. Jain A, Lam A, Vivanco I et al. Identification of an androgen-dependent enhancer within the prostate stem cell antigen. Mol. Endocrinol. 2002 16 : 2323 37.
26. Watabe T, Lin M, Donjacour AA et al. Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promotor. Proc. Natl Acad. Sci. USA 2002 99 : 401 6.